Associate Professor, College of Pharmacy - Pharmaceutical Sciences
Director of Graduate Studies, College of Pharmacy - Pharmaceutical Sciences
833 S. Wood St. MC 781, Chicago, IL
Terry W. Moore is an associate professor of medicinal chemistry in the College of Pharmacy at the University of Illinois at Chicago. His research program focuses on designing, synthesizing, and characterizing new small molecule and peptide probes to modulate transcription factors, including nuclear receptors and NRF2. Dr. Moore’s lab at UIC uses the tools of synthetic medicinal chemistry, peptide chemistry, drug discovery and chemical biology. He is a member of the Early Career Board of ACS Medicinal Chemistry Letters, and he was a member of the organizing committee of the 2019 EFMC/MEDI Frontiers in Medicinal Chemistry Symposium in Krakow. Dr. Moore is a guest co-editor of a recent special issue of Molecular and Cellular Endocrinology on “Alternative Nuclear Receptor Ligands.” Because of these efforts, Dr. Moore was named the UIC “Rising Star” Researcher of the Year for the Basic Life Sciences in 2018.
Drug Discovery; medicinal chemistry; peptide chemistry
Teaching and Supervision
PSCI Ph.D. Thesis Research (PSCI 599), 6/14/2021 – 8/6/2021
Doctoral Restch in Med Chem (MDCH 599), 6/14/2021 – 8/6/2021
Medicinal Chemistry (PSCI 530), 1/11/2021 – 4/30/2021
Doctoral Restch in Med Chem (MDCH 599), 1/11/2021 – 4/30/2021
Pharm Sciences Rotation (PSCI 592), 1/11/2021 – 4/30/2021
Doctoral Restch in Med Chem (MDCH 599), 8/24/2020 – 12/4/2020
Pharm Sciences Rotation (PSCI 592), 8/24/2020 – 12/4/2020
Fundamentals of Drug Action (PHAR 422), 8/24/2020 – 12/4/2020
Fundamentals of Drug Action (PHAR 422), 8/24/2020 – 12/4/2020
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action, National Institutes of Health (National Institute of Allergy and Infectious Diseases)., 7/16/2021 - 6/30/2022, Obligated Amount: $730027; Anticipated Amount: $730027
Selective Antagonists of Mutant Estrogen Receptors, American Cancer Society., 7/1/2021 - 6/30/2025, Obligated Amount: $792000; Anticipated Amount: $792000
Development of 4-(aroylamino) piperidine-based entry inhibitors as anti-influenza therapeutics, Chicago BioSolutions Inc., 4/2/2021 - 3/31/2022, Obligated Amount: $150310; Anticipated Amount: $150310
Visiting Scientist Agreement with Jordan University of Science and Technology, Jordan Univ of Science & Technology., 1/1/2021 - 12/31/2026, No Obligated Amount Set; No Anticipated Amount Set
DUA - ACS Bridge Program Partnership, Amer Chemical Soc., 8/12/2020 - 8/11/2023, No Obligated Amount Set; No Anticipated Amount Set
4- (Aminomethyl) Benzamides as Novel Anti-Ebola Agents, Chicago BioSolutions Inc., 8/16/2019 - 11/30/2020, Obligated Amount: $596030; Anticipated Amount: $596030
Development of group 2 influenza A virus entry inhibitors, Chicago BioSolutions Inc., 4/1/2019 - 3/31/2022, Obligated Amount: $336139; Anticipated Amount: $336139
Visiting Scientist Agreement with Jordan University of Science and Technology, Jordan Univ of Science & Technology., 1/1/2019 - 12/31/2024, No Obligated Amount Set; No Anticipated Amount Set
Role of Nrf2 in Alveolar Epithelial Cell Regeneration During Lung Repair, National Institutes of Health (National Heart, Lung, and Blood Institute)., 8/10/2017 - 6/30/2022, Obligated Amount: $2052653; Anticipated Amount: $2052653
Horie, Y, Suzuki, T, Inoue, J, Iso, T, Wells, G, Moore, TW, Mizushima, T, Dinkova-Kostova, AT, Kasai, T, Kamei, T, Koshiba, S, Yamamoto, M. (2021). Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism. Communications Biology, 4, (1). doi:10.1038/s42003-021-02100-6.
Pomerantz, William CK. (2021). In This Issue, Volume 12, Issue 9. ACS Medicinal Chemistry Letters, 12, (9), 1357-1358. doi:10.1021/acsmedchemlett.1c00447.
Amaya, M, Cheng, H, Borisevich, V, Navaratnarajah, CK, Cattaneo, R, Cooper, L, Moore, TW, Gaisina, IN, Geisbert, TW, Rong, L, Broder, CC. (2021). A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Research, 193. doi:10.1016/j.antiviral.2021.105084.
Moore, Terry W. (2021). In This Issue, Volume 12, Issue 8. ACS Medicinal Chemistry Letters, 12, (8), 1181-1182. doi:10.1021/acsmedchemlett.1c00395.
Baliga, C, Brown, TJ, Florin, T, Colon, S, Shah, V, Skowron, KJ, Kefi, A, Szal, T, Klepacki, D, Moore, TW, Vázquez-Laslop, N, Mankin, AS. (2021). Charting the sequence-activity landscape of peptide inhibitors of translation termination. Proceedings of the National Academy of Sciences of the United States of America, 118, (10). doi:10.1073/pnas.2026465118.
Zink, KE, Ludvik, DA, Lazzara, PR, Moore, TW, Mandel, MJ, Sanchez, LM. (2021). A small molecule coordinates symbiotic behaviors in a host organ. mBio, 12, (2), 1-11. doi:10.1128/mBio.03637-20.
Moore, Terry W. (2020). In This Issue, Volume 11, Issue 12. ACS Medicinal Chemistry Letters, 11, (12), 2342-2343. doi:10.1021/acsmedchemlett.0c00616.
Mbachu, OC, Howell, C, Simmler, C, Malca Garcia, GR, Skowron, KJ, Dong, H, Ellis, SG, Hitzman, RT, Hajirahimkhan, A, Chen, SN, Nikolic, D, Moore, TW, Vollmer, G, Pauli, GF, Bolton, JL, Dietz, BM. (2020). SAR study on estrogen receptor α/β activity of (Iso)flavonoids: Importance of prenylation, c-ring (un)saturation, and hydroxyl substituents. Journal of Agricultural and Food Chemistry, 68, (39), 10651-10663. doi:10.1021/acs.jafc.0c03526.
Zink, Katherine E, Tarnowski, Denise A, Lazzara, Phillip R, Moore, Terry W, Mandel, Mark J, Sanchez, Laura M. (2020). Discovery of a microbially produced small molecule in a host-specific organ. , 2020.08.17.254854. doi:10.1101/2020.08.17.254854.
Session Organizer for American Chemical Society Meeting: Academic Drug Discovery, American Chemical Society, 4/5/2021 - 4/9/2021
Promotion and Tenure Review, Albany College of Pharmacy and Health Sciences, 10/1/2020 - 11/8/2020
Session Organizer for American Chemical Society Meeting: Gamechangers in Medicinal Chemistry, American Chemical Society, 8/16/2020 - 8/20/2020
Molecular and Cellular Endocrinology, 2018 - 2019
Long-Range Planning Committee of ACS MEDI Division, American Chemical Society, 2018 - 2020
AACR Chemistry in Cancer Research, 2016 - 2019
MIKI meeting-in-miniature, 2014 - 2015
2020, PhLAMEs Mentor of the Year,
2018, UIC “Rising Star” award,
2018, MEDI Young Investigator Symposium Awardee, ACS National Meeting,
2017, UIC College of Pharmacy Vahlteich Research Award,
2014, UIC College of Pharmacy P1 Teacher of the Semester,
2014, American Association of Colleges of Pharmacy New Investigator Award,
2011, The Anthony Shuker Scientific Poster Award,
2011, Emory Head and Neck Cancer SPORE Career Development Award,
2005, Pfizer Fellowship Supporting Diversity in Organic Chemistry,
Ph.D., University of Illinois at Urbana-Champaign, United States, 2008
B.A. in Biochemistry, Abilene Christian University, United States, 2000
Postdoc, Emory Institute for Drug Development, United States, 2013
Postdoc, University of Illinois at Urbana Champaign, United States, 2009